100 results on '"Günaydin I"'
Search Results
2. Augenbeteiligung bei Morbus Behçet: Erste 5-Jahres-Ergebnisse zur Visusentwicklung nach Therapie mit Interferon alfa-2a
3. Articular involvement in patients with relapsing polychondritis
4. Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis
5. Therapieprinzipien von Hausärzten und Rheumatologen in Süddeutschland bei rheumatoider Arthritis und Gonarthrose
6. Therapeutic approaches of German and Turkish physicians to rheumatoid arthritis and to osteoarthritis of the knee
7. Influence of human recombinant interferon-α2a (rhIFN-α2a) on altered lymphocyte subpopulations and monocytes in Behçetʼs disease
8. Myeloablative immunosuppressive treatment with autologous haematopoietic stem cell transplantation in a patient with psoriatic arthropathy and monoclonal gammopathy of undetermined significance
9. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis
10. Assessment of keratoconjunctivitis sicca in patients with fibromyalgia: results of a prospective study
11. Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin
12. Design and cfd analysis of a 150kw 8-stage orc-rot (organic rankine cycle-radial outflow turbine) and performance degradation due to blade tip clearance of labyrinth seal
13. Lower limb pitting edema in systemic lupus erythematosus
14. Collagenous colitis associated with rheumatoid arthritis and anticardiolipin antibodies
15. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a
16. MAGIC or not MAGIC--does the MAGIC (mouth and genital ulcers with inflamed cartilage) syndrome really exist? A case report and review of the literature
17. a new option for the treatment of chronic cystoid macular edema in uveitis?
18. Efficacy and safety of willow bark extract in the treatmant of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials
19. Interferon alfa-2a
20. Magnetresonanz – gesteuerte Kortikosteroid – Infiltration der Sakroiliakalgelenke: Spondylitis ankylosans vs. undifferenzierter Spondylarthropathie
21. Magnetic resonance imaging guided corticosteroid injection of sacroiliac joints in patients with spondylarthropathy. Are multiple injections more beneficial?
22. MR-gesteuerte Kortikosteroid-Infiltration der Sakroiliakalgelenke: Eine wirksame Option in der Behandlung der therapierefraktären Sakroiliitis bei Spondylitis ankylosans
23. Magnetresonanzgesteuerte Kortikosteroid-Infiltration der Sakroiliakalgelenke: Schmerztherapie der Sakroiliitis bei Patienten mit Spondylitis ankylosans
24. The use of interferon-alfa in Behçet's disease: review of the literature
25. Analgesic effects of willow bark extract in osteoarthritis: results of a clinical double‐blind trial
26. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
27. Behçet's Disease in Patients of German and Turkish Origin Living in Germany: A Comparative Analysis
28. Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis
29. Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease
30. Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature
31. [Corticosteroid injections of the sacroiliac joint during magnetic resonance: preliminary results]
32. Transmission of psoriatic arthritis by allogeneic bone marrow transplantation for chronic myelogenous leukaemia from an HLA-identical donor.
33. Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behçet's disease and influence on cells of the immune system: results of an open four center trial
34. Letter. Transmission of psoriatic arthritis by allogeneic bone marrow transplantation for chronic myelogenous leukaemia from an HLA-identical donor
35. The use of interferon-alfa in Behçet's disease: review of the literature
36. Functional gastrointestinal disorders in patients with familial Mediterranean fever.
37. Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up.
38. MAGIC or not MAGIC--does the MAGIC (mouth and genital ulcers with inflamed cartilage) syndrome really exist? A case report and review of the literature.
39. CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.
40. Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature.
41. [Magnetic resonance imaging -- guided corticosteroid-infiltration of the sacroiliac joints: pain therapy of sacroiliitis in patients with ankylosing spondylitis].
42. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
43. The use of interferon alpha in Behçet disease: review of the literature.
44. Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial.
45. [Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a].
46. Behçet's disease in patients of German and Turkish origin living in Germany: a comparative analysis.
47. Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment.
48. Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease.
49. The use of interferon-alpha in Behçet's disease--review of the literature and possible mechanisms of action.
50. Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.